Fundz

LigaChem Biosciences Appoints Rodrigo Ruiz Soto as Chief Medical Officer (CMO)

PRIVATEOct 23, 2024

Position

Chief Medical Officer

Company

LigaChem Biosciences

Rodrigo Ruiz Soto
DaejeonBiotechnologyHealth CareTherapeutics

Description

LigaChem Biosciences announces the appointment of Dr. Rodrigo Ruiz Soto as the Chief Medical Officer (CMO)

Quick answer

LigaChem Biosciences Appoints Rodrigo Ruiz Soto as Chief Medical Officer (CMO) (October 23, 2024). LigaChem Biosciences is based in Daejeon, Daejeon, South Korea.

Who is the new Chief Medical Officer at LigaChem Biosciences?
LigaChem Biosciences named Rodrigo Ruiz Soto Chief Medical Officer, announced October 23, 2024.
What did LigaChem Biosciences announce on October 23, 2024?
LigaChem Biosciences announces the appointment of Dr. Rodrigo Ruiz Soto as the Chief Medical Officer (CMO)
What does LigaChem Biosciences do?
LigaChem Biosciences is dedicated to the discovery and development of innovative therapies that leverage the power of antibody-drug conjugates to treat cancer and other serious diseases.
Where is LigaChem Biosciences based?
LigaChem Biosciences is based in Daejeon, Daejeon, South Korea.
Which similar companies made leadership changes around the same time?
RYNE Biotechnology (October 23, 2024), Parexel (October 22, 2024), Arialys Therapeutics (October 22, 2024) and HuidaGene Therapeutics (October 21, 2024) also announced leadership changes within 45 days of LigaChem Biosciences.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at LigaChem Biosciences, and when

A new leader at LigaChem Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day LigaChem Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LigaChem Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LigaChem Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LigaChem Biosciences

Location

Daejeon, Daejeon, South Korea

About

LigaChem Biosciences is dedicated to the discovery and development of innovative therapies that leverage the power of antibody-drug conjugates to treat cancer and other serious diseases. Our mission is to improve the quality of life for patients by providing effective and targeted treatment options.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LigaChem Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Yun-Hee
Senior decision-maker at this company
••••••••@••••••••

See Yun-Hee's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for LigaChem Biosciences's next move

Learn about Strategic plan

LigaChem Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.